Correlation Between Lyell Immunopharma and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Lyell Immunopharma and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Acrivon Therapeutics,.
Diversification Opportunities for Lyell Immunopharma and Acrivon Therapeutics,
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Lyell and Acrivon is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Lyell Immunopharma and Acrivon Therapeutics,
Given the investment horizon of 90 days Lyell Immunopharma is expected to under-perform the Acrivon Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Lyell Immunopharma is 1.08 times less risky than Acrivon Therapeutics,. The stock trades about -0.01 of its potential returns per unit of risk. The Acrivon Therapeutics, Common is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 441.00 in Acrivon Therapeutics, Common on August 27, 2024 and sell it today you would earn a total of 214.00 from holding Acrivon Therapeutics, Common or generate 48.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyell Immunopharma vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Lyell Immunopharma |
| Acrivon Therapeutics, |
Lyell Immunopharma and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyell Immunopharma and Acrivon Therapeutics,
The main advantage of trading using opposite Lyell Immunopharma and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |